The effects of methanolic extract of Glycyrrhiza glabra on the prevention and treatment of bleomycin-induced pulmonary fibrosis in rat: experimental study

References

• Adamson, I.Y. and Bowden, D.H., 1974. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. The American Journal of Pathology, 77, 185–197.
   PubMed Web of Science ®Google Scholar
• Akamatsu, H., et al., 1991. Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation. Planta Medica, 57 (02), 119–121.
   PubMed Web of Science ®Google Scholar
• Aoki, F., et al., 2005. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. American Journal of Respiratory and Critical Care Medicine, 172 (6), 713–720.
   PubMed Web of Science ®Google Scholar
• Ashcroft, T., Simpson, J.M., and Timbrell, V., 1988. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. Journal of Clinical Pathology, 41 (4), 467–470.
   PubMed Web of Science ®Google Scholar
• Beers, R.F., Jr. and Sizer, I.W., 1952. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. The Journal of Biological Chemistry, 195, 133–140.
   PubMed Web of Science ®Google Scholar
• Benzie, I.F. and Strain, J.J., 1999. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods in Enzymology, 299, 15–27.
   PubMed Web of Science ®Google Scholar
• Chandrasekaran, C.V., et al., 2011. Dual inhibitory effect of Glycyrrhiza glabra (GutGard) on COX and LOX products. Phytomedicine, 18 (4), 278–284.
   PubMed Web of Science ®Google Scholar
• Esterbauer, H. and Cheeseman, K.H., 1990. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods in Enzymology, 186, 407–421.
   PubMed Web of Science ®Google Scholar
• Fukuda, Y., et al., 1995. Significance of early intra-alveolar fibrotic lesions and integrin expression in lung biopsy specimens from patients with idiopathic pulmonary fibrosis. Human Pathology, 26 (1), 53–61.
   PubMed Web of Science ®Google Scholar
• Gao, J., et al., 2012. Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodelling. Journal of Pharmacy and Pharmacology, 64 (6), 811–820.
   PubMed Web of Science ®Google Scholar
• Gao, L., et al., 2015. Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats. Frontiers in Pharmacology, 6, 215.
   PubMed Web of Science ®Google Scholar
• Genovese, T., et al., 2009. Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice. Shock, 31 (4), 367–375.
   PubMed Web of Science ®Google Scholar
• Heilmann, P., et al., 1999. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine. Experimental and Clinical Endocrinology & Diabetes, 107 (06), 370–378.
   PubMed Web of Science ®Google Scholar
• Hocaoglu, A.B., et al., 2011a. Glycyrrhizin and long-term histopathologic changes in a murine model of asthma. Current Therapeutic Research, 72 (6), 250–261.
   PubMed Web of Science ®Google Scholar
• Hocaoglu, A.B., et al., 2011b. Glycyrrhizin and long-term histopathologic changes in a murine model of asthma. Current Therapeutic Research, Clinical and Experimental, 72 (6), 250–261.
   PubMed Web of Science ®Google Scholar
• Ishida, T., et al., 2012. Inhibitory effects of glycyrrhetinic acid on DNA polymerase and inflammatory activities. Evidence-Based Complementary and Alternative Medicine, 2012, 650514.
   PubMed Web of Science ®Google Scholar
• Izbicki, G., et al., 2002. Time course of bleomycin-induced lung fibrosis. International Journal of Experimental Pathology, 83 (3), 111–119.
   PubMed Web of Science ®Google Scholar
• Kim, S.W., et al., 2012. Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion. Neurobiology of Disease, 46 (1), 147–156.
   PubMed Web of Science ®Google Scholar
• Korenaga, M., et al., 2011. A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice. Liver International, 31 (4), 552–560.
   PubMed Web of Science ®Google Scholar
• Kroes, B.H., et al., 1997. Inhibition of human complement by beta-glycyrrhetinic acid. Immunology, 90 (1), 115–120.
   PubMed Web of Science ®Google Scholar
• Krous, H.F. and Hamlin, W.B., 1973. Pulmonary toxicity due to bleomycin. Report of a case. Archives of Pathology, 95 (6), 407–410.
   PubMedGoogle Scholar
• Kudo, T., et al., 2011. Topical application of glycyrrhizin preparation ameliorates experimentally induced colitis in rats. World Journal of Gastroenterology, 17 (17), 2223–2228.
   PubMed Web of Science ®Google Scholar
• Li, X.L., et al., 2011. Antioxidant status and immune activity of glycyrrhizin in allergic rhinitis mice. International Journal of Molecular Sciences, 12 (2), 905–916.
   PubMed Web of Science ®Google Scholar
• Liang, X., et al., 2011. Effect of Feining on bleomycin-induced pulmonary injuries in rats. Journal of Ethnopharmacology, 134 (3), 971–976.
   PubMed Web of Science ®Google Scholar
• Ma, C., et al., 2013. Immunoregulatory effects of glycyrrhizic acid exerts anti-asthmatic effects via modulation of Th1/Th2 cytokines and enhancement of CD4(+)CD25(+)Foxp3+ regulatory T cells in ovalbumin-sensitized mice. Journal of Ethnopharmacology, 148 (3), 755–762.
   PubMed Web of Science ®Google Scholar
• Ma, Z., et al., 2018. Antifibrotic effects of a novel pirfenidone derivative in vitro and in vivo. Pulmonary Pharmacology & Therapeutics, 53, 100–106.
   PubMed Web of Science ®Google Scholar
• Mandegary, A., et al., 2012. Oxidative stress induced in the workers of natural gas refineries, no role for GSTM1 and GSTT1 polymorphisms. Human & Experimental Toxicology, 31, 1271–1279.
   PubMed Web of Science ®Google Scholar
• Margaritopoulos, G.A., et al., 2018. Pirfenidone improves survival in IPF: results from a real-life study. BMC Pulmonary Medicine, 18, 177–184.
   PubMed Web of Science ®Google Scholar
• Mason, R.J., NHLBI Workshop Summary., et al., 1999. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future. American Journal of Respiratory and Critical Care Medicine, 160 (5), 1771–1777.
   PubMedGoogle Scholar
• Menegazzi, M., et al., 2008. Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice. Pharmacological Research, 58 (1), 22–31.
   PubMed Web of Science ®Google Scholar
• Muralidharan, P., Balamurugan, G., and Babu, V., 2009. Cerebroprotective effect of Glycyrrhiza glabra Linn. root extract on hypoxic rats. Bangladesh Journal of Pharmacology, 4, 60–64.
   Web of Science ®Google Scholar
• Ni, Y.F., et al., 2011. Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression. Journal of Surgical Research, 165 (1), e29–e35.
   PubMed Web of Science ®Google Scholar
• Okimasu, E., et al., 1983. Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug. Acta Medica Okayama, 37 (5), 385–391.
   PubMed Web of Science ®Google Scholar
• Pompei, R., et al., 1979. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature, 281 (5733), 689–690.
   PubMed Web of Science ®Google Scholar
• Qamar, W., et al., 2012. Alleviation of lung injury by glycyrrhizic acid in benzo(a)pyrene exposed rats: probable role of soluble epoxide hydrolase and thioredoxin reductase. Toxicology, 291 (1–3), 25–31.
   PubMed Web of Science ®Google Scholar
• Quan, T.E., Cowper, S.E., and Bucala, R., 2006. The role of circulating fibrocytes in fibrosis. Current Rheumatology Reports, 8 (2), 145–150.
   PubMedGoogle Scholar
• Reddy, G.K. and Enwemeka, C.S., 1996. A simplified method for the analysis of hydroxyproline in biological tissues. Clinical Biochemistry, 29, 225–229.
   PubMed Web of Science ®Google Scholar
• Samareh Fekri, M., et al., 2018. Protective effect of standardized extract of Myrtus communis L.(myrtle) on experimentally bleomycin-induced pulmonary fibrosis: biochemical and histopathological study. Drug and Chemical Toxicology, 41, 408–414.
   PubMed Web of Science ®Google Scholar
• Samareh Fekri, M., et al., 2013. Pulmonary complications of gastric fluid and bile salts aspiration, an experimental study in rat. Iranian Journal of Basic Medical Sciences, 16, 790–796.
   PubMed Web of Science ®Google Scholar
• Sgalla, G., et al., 2018. Idiopathic pulmonary fibrosis: pathogenesis and management. Respiratory Research, 19 (1), 32.
   PubMed Web of Science ®Google Scholar
• Shamim, A., et al., 2016. Effect of ethanolic extract of Glycyrizza glabra against streptozotocin and high-fat diet-induced diabetes and hyperlipidemia. International Journal of Pharmacy and Pharmaceutical Sciences, 8, 259–266.
   Google Scholar
• Sharififar, F., et al., 2010. Study the ethnobotany of medicinal plants in Sirjan, Kerman province, Iran. Journal of Herbal Drugs (An International Journal on Medicinal Herbs), 1, 19–28.
   Google Scholar
• Shi, W., et al., 2017. Inhibitory effect of compound Chuanxiong Kangxian granules on bleomycin-induced pulmonary fibrosis in rats. Biomedicine & Pharmacotherapy, 96, 1179–1185.
   PubMed Web of Science ®Google Scholar
• Sur, S., et al., 1999. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. Journal of Immunology, 162 (10), 6284–6293.
   PubMed Web of Science ®Google Scholar
• Takei, M., et al., 2005. Glycyrrhizin inhibits R5 HIV replication in peripheral blood monocytes treated with 1-methyladenosine. Pathobiology, 72 (3), 117–123.
   PubMed Web of Science ®Google Scholar
• Tu, C.T., et al., 2012. Glycyrrhizin regulates CD4+ T cell response during liver fibrogenesis via JNK, ERK and PI3K/AKT pathway. International Immunopharmacology, 14 (4), 410–421.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2011. Inhibitory effect of safflor yellow on pulmonary fibrosis. Biological & Pharmaceutical Bulletin, 34, 511–516.
   PubMed Web of Science ®Google Scholar
• Wang, A., et al., 2018. Dexamethasone reduces serum level of IL-17 in Bleomycin-A5-induced rats model of pulmonary fibrosis. Cells, Nanomedicine, and Biotechnology, 46 (4), 783–787.
   PubMed Web of Science ®Google Scholar
• Yu, W., Guo, F., and Song, X., 2017. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models. Pharmaceutical Biology, 55 (1), 450–455.
   PubMed Web of Science ®Google Scholar
• Woessner, J., Jr., 1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Archives of Biochemistry and Biophysics, 93 (2), 440–447.
   PubMed Web of Science ®Google Scholar
• Xiao, Z.W., et al., 2014. Therapeutic effect of magnesium isoglycyrrhizinate in rats on lung injury induced by paraquat poisoning. European Review for Medical and Pharmacological Sciences, 18, 311–320.
   PubMed Web of Science ®Google Scholar
• Yang, C.Q., et al., 2010. The ethical Kampo formulation Sho-seiryu-to (TJ-19) prevents bleomycin-induced pulmonary fibrosis in rats. Biological & Pharmaceutical Bulletin, 33, 1438–1442.
   PubMed Web of Science ®Google Scholar
• Yang, J., Cui, Y., and Kolb, M., 2009. How useful is traditional herbal medicine for pulmonary fibrosis? Respirology, 14 (8), 1082–1091.
   PubMed Web of Science ®Google Scholar
• Ye, S., et al., 2014. Glycyrrhizin protects mice against renal ischemia-reperfusion injury through inhibition of apoptosis and inflammation by downregulating p38 mitogen-activated protein kinase signaling. Experimental and Therapeutic Medicine, 7 (5), 1247–1252.
   PubMed Web of Science ®Google Scholar
• Zhang, D., et al., 2017. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4. International Immunopharmacology, 48, 67–75.
   PubMed Web of Science ®Google Scholar
• Zhou, X.M., et al., 2007. Inhibitory effects of Hu-qi-yin on the bleomycin-induced pulmonary fibrosis in rats. Journal of Ethnopharmacology, 111 (2), 255–264.
   PubMed Web of Science ®Google Scholar